GE HealthCare (GEHC) Tops Q2 EPS by 2c, cuts revenue guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GE HealthCare (GEHC) PT Raised to $92 at Jefferies
July 31, 2024 3:50 PM EDTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $92.00 (from $87.00) while maintaining a Hold rating.
The analyst comments "GEHC reported 2Q24 sales of $4.84B, +1% organic vs cons $4.88B, and EPS of $1.00 (+9%) vs cons $0.98. Orders increased +3%... More
GE HealthCare (GEHC) beats earnings but cuts full-year revenue outlook amid China headwinds
July 31, 2024 6:43 AM EDTGE HealthCare (NASDAQ: GEHC) delivered better-than-expected second-quarter earnings, but the company has tempered its full-year outlook due to headwinds in the Chinese market, sending its shares more than 8% lower in premarket trading.
While the medical technology giant reported adjusted earnings per share (EPS) of $1.00, surpassing analyst estimates by $0.02, revenue came in at $4.84 billion, slightly below expectations of $4.87 billion.
The company attributed the revenue shortfall to... More
